Releuko 300 mcg/mL injection Images
Generic Name: filgrastim
This medication has been identified as Releuko 300 mcg/mL injection. It is supplied by Amneal Pharmaceuticals LLC.
Releuko is used in the treatment of Neutropenia; Neutropenia Associated with Chemotherapy; Bone Marrow Transplantation and belongs to the drug class colony stimulating factors. Risk cannot be ruled out during pregnancy. Releuko 300 mcg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Releuko
- Generic Name
- filgrastim
- Strength
- 300 mcg/mL injection
- Availability
- Prescription only
- Drug Class
- Colony stimulating factors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 70121-1569
More about Releuko (filgrastim)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: colony stimulating factors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
